Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
1.
Breast Dis ; 42(1): 305-313, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37807773

RESUMO

Breast cancer is the most incidental and deadly neoplasm worldwide; in Mexico, very few epidemiologic reports have analyzed the pathological features and its impact on their clinical outcome. Here, we studied the relation between pathological features and the clinical presentation at diagnosis and their impact on the overall and progression-free survival of patients with breast cancer. For this purpose, we collected 199 clinical records of female patients, aged at least 18 years old (y/o), with breast cancer diagnosis confirmed by biopsy. We excluded patients with incomplete or conflicting clinical records. Afterward, we performed an analysis of overall and progression-free survival and associated risks. Our results showed an average age at diagnosis of 52 y/o (24-85), the most common features were: upper outer quadrant tumor (32%), invasive ductal carcinoma (76.8%), moderately differentiated (44.3%), early clinical stages (40.8%), asymptomatic patients (47.8%), luminal A subtype (47.8%). Median overall survival was not reached, but median progression-free survival was 32.2 months (29.75-34.64, CI 95%) associated risk were: clinical stage (p < 0.0001) symptomatic presentation (p = 0.009) and histologic grade (p = 0.02). Therefore, we concluded that symptom presence at diagnosis impacts progression-free survival, and palpable symptoms are related to an increased risk for mortality.


Assuntos
Neoplasias da Mama , Carcinoma Ductal de Mama , Adulto , Feminino , Humanos , Neoplasias da Mama/patologia , Carcinoma Ductal de Mama/patologia , México/epidemiologia , Estadiamento de Neoplasias , Prognóstico , Estudos Retrospectivos , Adulto Jovem , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais
2.
Eur J Haematol ; 108(3): 169-177, 2022 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-34779527

RESUMO

OBJECTIVE: To explore whether the growth and treatment resistance of lymphoma and myeloma tumors is similar to that previously observed in leukemic and solid tumors growing in the same organ microenvironment. METHODS: All published cases of 3 primary hematologic malignancies in breast, without systemic involvement, were identified, with follow-ups solicited from authors. Treatment approaches were analyzed to highlight the most effective. RESULTS: Similar histologic features and biology among primary tumors of leukemia, lymphoma, plasmacytoma, and solid breast cancer was revealed. Review of treatments: tumor-directed, chemotherapy, or combination showed the benefit of tumor removal, and use of systemic agents in adjunct, not primary, treatment. Optimal assessment is limited by few cases of PET/CT verifying limited tumor extent. The common biology observed and cases of long survival after tumor/stroma eradication point to the complicity of organ microenvironment in the chemoresistance and treatment failure commonly observed in patients. CONCLUSIONS: The interaction of an organ microenvironment, particularly its adipocytes, with malignant cells, results in similar histologic changes, metastatic potential, and chemoresistance in 3 hematologic malignancies and solid cancers. Improved survival in hematologic malignancies could result from adopting PET/CT to find tumor and its extent, eradicating tumor, and elucidating common therapeutic targets.


Assuntos
Neoplasias Hematológicas , Leucemia , Linfoma , Mieloma Múltiplo , Neoplasias Hematológicas/patologia , Humanos , Leucemia/patologia , Linfoma/patologia , Mieloma Múltiplo/diagnóstico , Mieloma Múltiplo/terapia , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , Microambiente Tumoral
3.
Oncology ; 96(4): 207-216, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30476928

RESUMO

OBJECTIVE: Latin American countries are heterogeneous in terms of lung cancer incidence and exposure to potential carcinogens. We evaluated the frequency and clinical characteristics of ALK rearrangements (ALKr) in Latin America. METHODS: A total of 5,130 lung cancer patients from 10 Latin American countries were screened for inclusion. ALKr detection was performed by fluorescence in situ hybridization (FISH), immunohistochemistry (IHC), and real-time reverse transcriptase-polymerase chain reaction (RT-PCR) to assess method variability. Demographic and clinicopathologic characteristics were analyzed. RESULTS: Among the 5,130 patients screened, 8.4% (n = 433) had nonevaluable FISH tests. Evaluable FISH analyses revealed positive ALKr in 6.8% (320/4,697) of the study population, which included patients from 9 countries. ALKr distribution for each country was: Mexico 7.6% (79/1,034), Colombia 4.1% (10/242), Argentina 6.0% (153/2,534), Costa Rica 9.5% (13/137), Panama 4.4% (5/114), Uruguay 5.4% (2/37), Chile 8.6% (16/185), Venezuela 8.9% (13/146), and Peru 10.8% (29/268). RT-PCR showed high positive (83.6%) and negative (99.7%) predictive values when compared to the gold standard FISH. In contrast, IHC only showed a high negative predictive value (94.6%). CONCLUSIONS: Although there is a clear country and continental variability in terms of ALKr frequency, this difference is not significant and the overall incidence of ALKr in Latin America does not differ from the rest of the world.


Assuntos
Adenocarcinoma de Pulmão/epidemiologia , Adenocarcinoma de Pulmão/genética , Quinase do Linfoma Anaplásico/genética , Biomarcadores Tumorais/genética , Rearranjo Gênico , Adenocarcinoma de Pulmão/diagnóstico , Idoso , Feminino , Predisposição Genética para Doença , Humanos , Imuno-Histoquímica , Hibridização in Situ Fluorescente , Incidência , América Latina/epidemiologia , Masculino , Pessoa de Meia-Idade , Epidemiologia Molecular , Prevalência , Reação em Cadeia da Polimerase em Tempo Real , Estudos Retrospectivos , Reação em Cadeia da Polimerase Via Transcriptase Reversa
4.
Plast Reconstr Surg Glob Open ; 5(2): e1248, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-28280682

RESUMO

This study describes a case report of a 31-year-old patient who presented with a left thoracic tumor on costal cartilages 5 and 6 that was diagnosed as a desmoid tumor 3 years after receiving retropectoral breast implants for cosmetic reasons. The integral reconstruction of the thoracic wall, functional and aesthetic, was planned for a single surgical period. The defect secondary to the tumor resection, which left the pericardium and lung exposed, was closed using the pectoral muscle as a "pre-expanded" flap by the breast implant, and the breast aesthetic was treated bilaterally with new implants in the retromammary position. After 12 months, the patient remained free from tumor recurrence and had a satisfactory aesthetic result.

5.
Diagn Pathol ; 7: 154, 2012 Nov 07.
Artigo em Inglês | MEDLINE | ID: mdl-23134683

RESUMO

Primary sarcomas of the major blood vessels can be classified based on location in relationship to the wall or by histologic type. Angiosarcomas are malignant neoplasms that arise from the endothelial lining of the blood vessels; those arising in the intimal compartment of pulmonary artery are rare. We report a case of pulmonary artery angiosarcoma in a 36-year old female with pulmonary masses. The patient had no other primary malignant neoplasm, thus excluding a metastatic lesion. Gross examination revealed a thickened right pulmonary artery and a necrotic and hemorrhagic tumor, filling and occluding the vascular lumen. The mass extended distally, within the pulmonary vasculature of the right lung. Microscopically, an intravascular undifferentiated tumor was identified. The tumor cells showed expression for vascular markers VEGFR, VEGFR3, PDGFRa, FGF, Ulex europaeus, FVIII, FLI-1, CD31 and CD34; p53 was overexpressed and Ki67 proliferative rate was increased. Intravascular angiosarcomas are aggressive neoplasms, often associated with poor outcome.


Assuntos
Erros de Diagnóstico , Hemangiossarcoma/patologia , Histiocitoma Fibroso Maligno/patologia , Artéria Pulmonar/patologia , Neoplasias Vasculares/patologia , Adulto , Biomarcadores Tumorais/análise , Biópsia , Proliferação de Células , Quimioterapia Adjuvante , Feminino , Hemangiossarcoma/química , Hemangiossarcoma/terapia , Humanos , Imuno-Histoquímica , Fenótipo , Pneumonectomia , Valor Preditivo dos Testes , Artéria Pulmonar/química , Artéria Pulmonar/cirurgia , Tomografia Computadorizada por Raios X , Resultado do Tratamento , Neoplasias Vasculares/química , Neoplasias Vasculares/terapia
7.
Pediatr Dev Pathol ; 14(4): 327-32, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21385006

RESUMO

Bladder paraganglioma (BP) is a rare entity and is exceedingly uncommon in childhood. Pheochromocytomas/paragangliomas are components of several hereditary cancer syndromes, and up to 30% may be associated with germ-line mutations of genes, including VHL, RET, and SDH. We present a 16-year-old female who was admitted with macroscopic hematuria and anemia. A cystoscopy demonstrated a polypoid and hemorrhagic mass arising from the floor of the bladder. She underwent a transurethral resection of clinically suspected urothelial papilloma. A histologic examination of the tumor showed large polygonal cells with eosinophilic cytoplasm, arranged in a zellballen pattern, surrounded by a fibrous network. Immunohistochemical studies showed a strong expression of neuroendocrine markers and lack of reactivity for epithelial markers. The diagnosis of BP was established; eight months later, a recurrence was observed and the patient underwent a partial cystectomy. Our case represents the 1st BP in childhood reported in the literature with absent SDHB staining by immunohistochemistry. We discuss the clinical and pathologic findings and present a review of BP in childhood.


Assuntos
Paraganglioma Extrassuprarrenal/patologia , Neoplasias da Bexiga Urinária/patologia , Adolescente , Feminino , Humanos , Imuno-Histoquímica , Recidiva Local de Neoplasia/patologia , Recidiva Local de Neoplasia/cirurgia , Paraganglioma Extrassuprarrenal/metabolismo , Paraganglioma Extrassuprarrenal/cirurgia , Neoplasias da Bexiga Urinária/metabolismo , Neoplasias da Bexiga Urinária/cirurgia
8.
Ann Diagn Pathol ; 14(5): 365-8, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20850702

RESUMO

Basal cell proliferations within the prostate gland encompass a group of benign and malignant entities. Although basal cell hyperplasia is a common finding, basal cell carcinoma of the prostate gland is a rare tumor that can be mistaken by a benign condition and represents a diagnostic problem in genitourinary pathology. We report a case of basal cell carcinoma in a previously healthy 65-year-old man with urinary symptoms and low prostate-specific antigen. The microscopic findings are presented and the use of immunohistochemical markers classifying basal cell lesions of the prostate discussed.


Assuntos
Biomarcadores Tumorais/análise , Carcinoma Basocelular/diagnóstico , Neoplasias da Próstata/diagnóstico , Idoso , Biomarcadores Tumorais/metabolismo , Carcinoma Basocelular/química , Carcinoma Basocelular/imunologia , Carcinoma Basocelular/patologia , Diagnóstico Diferencial , Humanos , Masculino , Próstata/metabolismo , Próstata/patologia , Antígeno Prostático Específico/análise , Antígeno Prostático Específico/metabolismo , Neoplasias da Próstata/química , Neoplasias da Próstata/imunologia , Neoplasias da Próstata/patologia , Sensibilidade e Especificidade
9.
Int J Clin Exp Pathol ; 3(6): 600-7, 2010 Jun 30.
Artigo em Inglês | MEDLINE | ID: mdl-20661408

RESUMO

BLBC represents a distinctive group of invasive breast carcinomas with specific genotype and immunoprofile. BLBC is usually defined by gene expression profiling and is currently associated with poor outcome. BLBCs are estrogen receptor (ER) negative, progesterone receptor (PgR) negative, HER2 negative, and usually show a variable expression of basal cytokeratins (CKs), EGFR and CD117. p16(INK4a) is a tumor suppressor protein, encoded by the CDKN2A gene, which regulates cell cycle. The reported association of abnormalities in the p16/Rb pathway with increased risk of malignancy prompted us to determine the expression of p16(INK4a) in a group of BLBC; the results were compared with a group of high-grade invasive carcinoma (HG-IC) of breast. Tissue microarrays (TMA) were constructed in triplicate including 18 BLBC and 18 HG-IC. All BLBC cases were ER-/PgR-/HER2-. Seventeen (94%) BLBC were CK 5/6+/CK 14+; 14 (78%) BLCB showed EGFR expression and 13 (72%) were CD117 positive. BLBCs showed a strong positive reaction with p16(INK4a) antibody in 16 of 18 (89%) cases. Although the significance of p16(INK4a) expression in breast cancer is not fully understood, we have shown that p16(INK4a) is strongly expressed in breast cancers with basal-like phenotype. Since it is known that p16(INK4a) is associated with aggressive behavior in human carcinomas, these data suggest that p16(INK4a) play a role in the poor prognosis of BLBC.


Assuntos
Neoplasias da Mama/metabolismo , Inibidor p16 de Quinase Dependente de Ciclina/biossíntese , Perfilação da Expressão Gênica , Neoplasia de Células Basais/metabolismo , Neoplasias da Mama/genética , Neoplasias da Mama/patologia , Inibidor p16 de Quinase Dependente de Ciclina/genética , Feminino , Expressão Gênica , Humanos , Imuno-Histoquímica , Neoplasia de Células Basais/genética , Neoplasia de Células Basais/patologia , Receptor ErbB-2/biossíntese , Receptor ErbB-2/genética , Receptores de Estrogênio/biossíntese , Receptores de Estrogênio/genética , Receptores de Progesterona/biossíntese , Receptores de Progesterona/genética , Análise Serial de Tecidos
11.
World J Gastroenterol ; 14(46): 7107-11, 2008 Dec 14.
Artigo em Inglês | MEDLINE | ID: mdl-19084918

RESUMO

AIM: To investigate the presence of human papillomavirus (HPV) in esophageal squamous papilloma (ESP) and determine p16, p53 and Ki67 expression in a Mexican cohort. METHODS: Nineteen cases diagnosed as ESP, corresponding to 18 patients were reviewed; nineteen cases of normal esophageal mucosa were used as negative controls. HPV detection was performed by amplified chromogenic in situ hybridization (ACISH) using a wide spectrum-cocktail probe and PCR. RESULTS: The average age at presentation was 46.3 years (range 28-72 years). Patients included four (22.22%) males and 14 (77.77%) females. The most frequent location was upper third (11 cases), followed by middle third (3 cases) and unknown site (5 cases). Immunohistochemistry (IHC) revealed basal and focal p53 expression in 17 cases (89%); p16 was expressed in eight cases (42.10%) and the Ki67 index ranged from 10% to 30%. HPV was detected in 14 out of 16 cases (87.5%) by ACISH: Twelve showed diffuse nuclear patterns and two showed granular patterns. HPV DNA was identified by PCR in 12 out of 14 cases (85.7%). Low-risk HPV types were detected in the most of the cases. CONCLUSION: This study provides identification of HPV infection in almost 80% of ESP using either ACISH or PCR; overall, all of these lesions show low expression of cell-cycle markers. We suggest ACISH as an alternative diagnostic tool for HPV detection in ESP.


Assuntos
Neoplasias Esofágicas/virologia , Papiloma/virologia , Papillomaviridae/classificação , Papillomaviridae/patogenicidade , Adulto , Idoso , Estudos de Casos e Controles , Estudos de Coortes , Inibidor p16 de Quinase Dependente de Ciclina/metabolismo , Neoplasias Esofágicas/metabolismo , Neoplasias Esofágicas/patologia , Feminino , Papillomavirus Humano 11/patogenicidade , Papillomavirus Humano 16/patogenicidade , Papillomavirus Humano 18/patogenicidade , Papillomavirus Humano 6/patogenicidade , Humanos , Hibridização In Situ , Antígeno Ki-67/metabolismo , Masculino , México , Pessoa de Meia-Idade , Papiloma/metabolismo , Papiloma/patologia , Reação em Cadeia da Polimerase , Estudos Retrospectivos , Proteína Supressora de Tumor p53/metabolismo
12.
J Autoimmun ; 29(4): 281-6, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17888626

RESUMO

Vitiligo is a rather common disease characterized by depigmentation of skin and mucosae due to the loss of melanocytes, most likely as a result of autoimmune phenomena. In this study we demonstrated apoptotic markers in residual melanocytes in skin biopsies of patients with vitiligo, as well as the presence of serum antibodies to melanocyte-specific antigens in the vast majority of patients. Moreover, we were able to prove that serum IgG antibodies from vitiligo patients, but not from healthy controls, were capable to penetrate into cultured melanocytes in vitro, and trigger them to engage in apoptosis. Our results are consonant with the theory that melanocyte-specific antibodies are responsible for the deletion of melanocytes through antibody penetration and apoptosis.


Assuntos
Apoptose/imunologia , Autoanticorpos/imunologia , Melanócitos/imunologia , Vitiligo/imunologia , Adolescente , Adulto , Animais , Autoanticorpos/sangue , Autoantígenos/imunologia , Criança , Pré-Escolar , Feminino , Humanos , Imunoglobulina G/sangue , Lactente , Melanócitos/patologia , Pessoa de Meia-Idade , Vitiligo/sangue , Vitiligo/patologia
13.
Am J Surg Pathol ; 31(5): 729-36, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17460457

RESUMO

We describe the histologic variants of papillary and follicular carcinomas associated with 109 spindle and giant cell carcinomas (SGCC) of the thyroid and determine the incidence of rhabdoid and thyroglobulin inclusions in these tumors. In addition, we searched for rhabdoid and thyroglobulin inclusions in 120 papillary carcinomas (PC) (all 15 variants included), 23 differentiated follicular carcinomas (DFC), (6 with insular pattern), 6 poorly differentiated follicular carcinomas (PDFC) and 34 follicular adenomas (FA). The following differentiated thyroid carcinomas coexisted with SGCC: 51 (46.8%) PC, (34 conventional type, 14 tall cell variant and 3 follicular variant), 6 (5.5%) DFC, 1 follicular carcinoma with insular pattern (0.9%), and 3 oncocytic carcinomas (2.8%). Eleven SGCC (10%) and 2 (33%) PDFC showed rhabdoid features, but lacked thyroglobulin inclusions. Thyroglobulin inclusions were found in 10 FA (29%), 8 (17%) follicular variants of PC and in 7 (30.4%) DFC. There were no rhabdoid inclusions in any of these differentiated thyroid tumors. Our findings support the hypothesis that most SGCC result from dedifferentiation or anaplastic transformation although the mechanisms that underlie this transformation remain unknown. The finding that only 1 (0.9%) SGCC was associated with follicular carcinoma with insular pattern contradicts the opinion that this tumor occupies an intermediate position between differentiated and anaplastic carcinomas. Rhabdoid features are markers of PDFC and SGCC while thyroglobulin inclusions are markers of FA and differentiated thyroid carcinomas with follicular phenotype.


Assuntos
Carcinoma de Células Gigantes/patologia , Carcinoma Papilar, Variante Folicular/patologia , Carcinoma/patologia , Corpos de Inclusão/patologia , Tumor Rabdoide/patologia , Tireoglobulina/metabolismo , Neoplasias da Glândula Tireoide/patologia , Carcinoma/metabolismo , Carcinoma de Células Gigantes/metabolismo , Carcinoma Papilar, Variante Folicular/metabolismo , Humanos , Técnicas Imunoenzimáticas , Corpos de Inclusão/metabolismo , Prognóstico , Tumor Rabdoide/metabolismo , Neoplasias da Glândula Tireoide/metabolismo
14.
Int J Hematol ; 85(2): 116-20, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17321988

RESUMO

Langerhans cell sarcoma (LCS) is a neoplastic proliferation of Langerhans cells that occurs in lymph nodes, liver, skin, spleen, lung, and bone. We report a case of LCS in a 47-year-old man with a 6-month history of scalp mass and cervical lymphadenopathy. Clinical and pathologic data were available. A histologic examination demonstrated a proliferation of cells with malignant cytologic features. Because of its poorly differentiated morphologic features, hematologic and nonhematologic entities were ruled out by immunohistochemical screening with a broad panel of antibodies. Ultrastructural studies demonstrating Birbeck granules and consistent expression of CD1a, S-100 protein, and langerin by immunohistochemistry were helpful in identifying the Langerhans cell origin.


Assuntos
Neoplasias de Cabeça e Pescoço/ultraestrutura , Células de Langerhans/ultraestrutura , Neoplasias Cutâneas/ultraestrutura , Grânulos Citoplasmáticos/metabolismo , Grânulos Citoplasmáticos/ultraestrutura , Regulação Neoplásica da Expressão Gênica , Neoplasias de Cabeça e Pescoço/metabolismo , Humanos , Células de Langerhans/metabolismo , Masculino , Pessoa de Meia-Idade , Proteínas de Neoplasias/biossíntese , Neoplasias Cutâneas/metabolismo
15.
Pediatr Dev Pathol ; 9(6): 496-500, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-17163793

RESUMO

Squamous cell carcinoma is a rare thyroid neoplasm that has been described exclusively in adults. We report what appears to be the first example of a primary squamous cell carcinoma of the thyroid gland arising in a background of Hashimoto's thyroiditis in an adolescent female. The tumor was well demarcated, confined to the right thyroid lobe, and did not metastasize, although follow up has been limited. The squamous cell carcinoma was well to moderately differentiated, and the stroma contained an abundant inflammatory infiltrate rich in lymphocytes and eosinophils. The lack of goblet cells, extracellular mucin, and extensive stromal sclerosis excluded the diagnosis of sclerosing mucoepidermoid carcinoma with eosinophilia. Immunohistochemical staining revealed focal expression of cytokeratin 7 and diffuse labeling with cytokeratin AE1/AE3. The squamous cell carcinoma overexpressed p53 protein and showed increased proliferative activity, as evidenced by the high MIB-1 labeling index. In contrast, the tumor did not show immunoreactivity for thyroglobulin or thyroid transcription factor 1.


Assuntos
Carcinoma de Células Escamosas/complicações , Doença de Hashimoto/complicações , Neoplasias da Glândula Tireoide/complicações , Adolescente , Biomarcadores Tumorais/metabolismo , Carcinoma de Células Escamosas/metabolismo , Carcinoma de Células Escamosas/patologia , Proliferação de Células , Intervalo Livre de Doença , Feminino , Doença de Hashimoto/metabolismo , Doença de Hashimoto/patologia , Humanos , Queratinas/metabolismo , Neoplasias da Glândula Tireoide/metabolismo , Neoplasias da Glândula Tireoide/patologia , Tireoidectomia , Proteína Supressora de Tumor p53/metabolismo
16.
Pathol Oncol Res ; 12(2): 111-4, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16799714

RESUMO

Fibrocartilaginous dysplasia is a variant of fibrous dysplasia in which extensive cartilaginous differentiation is identified. The amount of cartilage varies from case to case, however, no percentage has been proposed to consider this diagnosis. We present a 6-year-old girl with a two-year history of hip pain. Initial imaging studies of the right femur revealed a lucent lesion of the proximal shaft that extended into the femoral neck with ill-defined borders but well maintained cortex. Computed tomography scan demonstrated increased density of the medullary cavity but the cortex appeared intact. Curettage of the lesion was performed and fragments with cartilaginous appearance were obtained, weighing 45 g in total. Microscopically, the tumor revealed a cartilaginous (60%) and a fibro-osseous (40%) component; the former had increased cellularity and some chondrocytes displayed moderate atypia and binucleation, while the latter showed features of fibrous dysplasia. Areas of endochondral ossification and calcification were also identified. After five years of surgery this child is well and without evidence of recurrence. We discuss the differential diagnosis of this variant of fibrous dysplasia in the pediatric group.


Assuntos
Cartilagem/patologia , Displasia Fibrosa Óssea/diagnóstico , Displasia Fibrosa Óssea/patologia , Neoplasias Ósseas/diagnóstico , Neoplasias Ósseas/patologia , Cartilagem/diagnóstico por imagem , Diferenciação Celular , Criança , Condrócitos/patologia , Condrossarcoma/diagnóstico , Condrossarcoma/patologia , Diagnóstico Diferencial , Feminino , Displasia Fibrosa Óssea/diagnóstico por imagem , Humanos , Tomografia Computadorizada por Raios X
17.
Rev. gastroenterol. Méx ; 65(4): 179-183, oct.-dic. 2000. ilus, tab, CD-ROM
Artigo em Espanhol | LILACS | ID: lil-302930

RESUMO

mediante la exploración quirúrgica e identificación de los distomas adultos. El primer caso falleció por insuficiencia hepática y el segundo, recibió tratamiento con prazicuantel y se encuentra estable. Conclusiones: existen al menos cincuenta casos En México, la fasciolosis hepática es la parasitosis más común de la vía biliar. La infestación masiva es común en el ganado vacuno o bovino y en el hombre se presenta rara vez. Sólo existen dos informes previos de este evento y nosotros contribuimos con dos casos más. Presentación de casos. Ambos ocurrieron en pacientes cirróticos por alcohol, con historia de ingesta de berros (Nasturium officinalis) y se manifestaron con ictericia, dolor abdominal y dilatación coledociana. El diagnóstico se estableció de fasciolosis en México desde 1935, la mayoría de los cuales ha sido diagnosticada preoperatoriamente como colelitiasis, a pesar que en la mayoría había historia de ingesta de berros.


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Cirrose Hepática Biliar/etiologia , Fasciolíase , Fígado/parasitologia
18.
Rev. invest. clín ; 47(2): 139-42, mar.-abr. 1995. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-158866

RESUMO

Mujer de 26 años con un cuadro clínico de síndrome anémico, vómito postprandial y melena intermitente de seis meses de evolución. La homoglobina de ingreso fue de 3.5 g/dL. El estudio endoscópico mostró un tumor que ocupaba el 90 por ciento de la luz duodenal. Se tomaron biopsias que se informaron como duodenitis aguda y crónica erosiva. Con diagnóstico de probable leiomioma, se efectuó laparotomía exploradora con duodenotomía y se resecó un tumor pedunculado que correspondió a un hamartoma de glándulas de Brunner. Esto ocasionó obstrucción duodenal parcial y hemorragia del tubo digestivo, los dos síntomas más comunes de este tumor raro


Assuntos
Adulto , Humanos , Feminino , Tumor Adenomatoide/diagnóstico , Tumor Adenomatoide/genética , Duodeno/patologia , Glândulas Duodenais/patologia , Pólipos Adenomatosos/diagnóstico , Pólipos Adenomatosos/patologia
19.
Bol. méd. Hosp. Infant. Méx ; 51(12): 800-3, dic. 1994. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-147705

RESUMO

Se presenta el caso de un niño de dos años de edad cistinosis clásica, manifestada por síndrome de Fanconi (glucosuria, aminoaciduria y fosfaturia), raquitismo, talla baja, presencia de cristales de cistina en córnea y daño glomerular progresivo; demostrándose en le biopsia renal por medio de microscopia electrónica el acúmulo de los característicos cristales hexagonales de cistina. Debido a que la frecuencia de esta patología en nuestro país es muy baja, y el cuadro clínico de nuestro paciente es representativo de la variante infantil nefropática, decidimos realizar este informe


Assuntos
Pré-Escolar , Humanos , Masculino , Cistina , Cistina/metabolismo , Cistinose/diagnóstico , Cistinose/fisiopatologia , Erros Inatos do Metabolismo/diagnóstico , Erros Inatos do Metabolismo/fisiopatologia , Síndrome de Fanconi/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...